Development and validation of an intact cell assay for protein tyrosine phosphatases using recombinant baculoviruses

被引:15
作者
Cromlish, WA [1 ]
Payette, P [1 ]
Kennedy, BP [1 ]
机构
[1] Merck Frosst Canada Inc, Merck Frosst Ctr Therapeut Res, Dept Biochem & Mol Biol, Pointe Claire, PQ H9R 4P8, Canada
关键词
baculovirus; protein tyrosine phosphatase; p-nitrophenyl phosphate; vanadate; pervanadate; inhibitor;
D O I
10.1016/S0006-2952(99)00242-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have developed an intact cell assay to be used in the direct quantitation of protein tyrosine phosphatase (PTP) activity. Utilizing the baculovirus expression system, the assay readily allows for a direct activity readout for PTPs such as PTP1B or CD45. Infected Sf9 cells expressing either full-length PTP1B, full-length CD45, CD45 catalytic domain, or hCOX-1 (mock-infected) are harvested 29 hr post-infection, at which time cells are viable and the expressed proteins are processed, as well as localized to their predicted subcellular compartments. Assays are carried out in a 96-well format, with cells expressing the PTP of interest. Cells are preincubated with or without inhibitor and challenged with substrate, and the phosphatase activity is determined spectrophotometrically by monitoring the conversion of p-nitrophenyl phosphate to e-nitrophenol at OD405. Documented PTP inhibitors have been used to validate this assay system. This study demonstrates that a direct readout of PTP activity in intact cells can be achieved, thus providing a useful cell-based screen fur determining selective inhibitors of PTPs. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:1539 / 1546
页数:8
相关论文
共 34 条
  • [11] FUJIKI H, 1994, J BIOCHEM-TOKYO, V115, P1
  • [12] METABOLIC EFFECTS OF SODIUM METAVANADATE IN HUMANS WITH INSULIN-DEPENDENT AND NONINSULIN-DEPENDENT - DIABETES-MELLITUS IN-VIVO AND IN-VITRO STUDIES
    GOLDFINE, AB
    SIMONSON, DC
    FOLLI, F
    PATTI, ME
    KAHN, CR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (11) : 3311 - 3320
  • [13] HEFFETZ D, 1990, J BIOL CHEM, V265, P2896
  • [14] EFFECT OF VANADATE ON ELEVATED BLOOD-GLUCOSE AND DEPRESSED CARDIAC-PERFORMANCE OF DIABETIC RATS
    HEYLIGER, CE
    TAHILIANI, AG
    MCNEILL, JH
    [J]. SCIENCE, 1985, 227 (4693) : 1474 - 1477
  • [15] Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate
    Huyer, G
    Liu, S
    Kelly, J
    Moffat, J
    Payette, P
    Kennedy, B
    Tsaprailis, G
    Gresser, MJ
    Ramachandran, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) : 843 - 851
  • [16] PEROXIDE(S) OF VANADIUM - A NOVEL AND POTENT INSULIN-MIMETIC AGENT WHICH ACTIVATES THE INSULIN-RECEPTOR KINASE
    KADOTA, S
    FANTUS, IG
    DERAGON, G
    GUYDA, HJ
    HERSH, B
    POSNER, BI
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 147 (01) : 259 - 266
  • [17] Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor
    Lee, SR
    Kwon, KS
    Kim, SR
    Rhee, SG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (25) : 15366 - 15372
  • [18] Phenylarsine oxide and vanadate: Apparent paradox of inhibition of protein phosphotyrosine phosphatases in rat adipocytes
    Li, JP
    Elberg, G
    Shechter, Y
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1996, 1312 (03): : 223 - 230
  • [19] LIN JJ, 1992, J IMMUNOL, V149, P3182
  • [20] CORRELATION BETWEEN SRC FAMILY MEMBER REGULATION BY THE PROTEIN-TYROSINE-PHOSPHATASE CD45 AND TRANSMEMBRANE SIGNALING THROUGH THE T-CELL RECEPTOR
    MCFARLAND, EDC
    HURLEY, TR
    PINGEL, JT
    SEFTON, BM
    SHAW, A
    THOMAS, ML
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (04) : 1402 - 1406